RecruitingNot ApplicableNCT06607406

Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery

A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)


Sponsor

Wake Forest University Health Sciences

Enrollment

75 participants

Start Date

Jan 21, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to determine whether accelerated radiotherapy (involving 6 treatments per week) is better than standard radiotherapy (involving 5 treatments per week) at treating cancer of the head and neck when initiated more than 6 weeks after surgery.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether starting radiation therapy more than 6 weeks after head and neck cancer surgery affects treatment outcomes for patients with intermediate or high-risk disease. Current guidelines recommend starting radiation within 6 weeks, but delays often happen — this study aims to understand the real-world impact. **You may be eligible if...** - You have been diagnosed with squamous cell carcinoma (a type of cancer) of the mouth, throat, voice box, sinuses, or neck lymph nodes - Your cancer has specific risk features that require post-surgery radiation (such as large tumor size, spread to multiple lymph nodes, nerve or vascular invasion, or close surgical margins) - Your radiation is intended to cure the cancer, not just control it **You may NOT be eligible if...** - You do not have the required high-risk pathological features - Your radiation is not being given with curative intent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONAccelerated radiotherapy

6 fractions per week, BID fractions one day per week

RADIATIONConventional radiotherapy

5 fractions per week, daily M-F


Locations(3)

Levine Cancer Institute

Charlotte, North Carolina, United States

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States

Advocate Aurora Radiation Oncology

Milwaukee, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06607406


Related Trials